Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice
- PMID: 22157680
- DOI: 10.1038/nm.2548
Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice
Abstract
Congenital disorder of glycosylation-Ia (CDG-Ia, also known as PMM2-CDG) is caused by mutations in the gene that encodes phosphomannomutase 2 (PMM2, EC 5.4.2.8) leading to a multisystemic disease with severe psychomotor and mental retardation. In a hypomorphic Pmm2 mouse model, we were able to overcome embryonic lethality by feeding mannose to pregnant dams. The results underline the essential role of glycosylation in embryonic development and may open new treatment options for this disease.
Similar articles
-
New and potential strategies for the treatment of PMM2-CDG.Biochim Biophys Acta Gen Subj. 2020 Nov;1864(11):129686. doi: 10.1016/j.bbagen.2020.129686. Epub 2020 Jul 23. Biochim Biophys Acta Gen Subj. 2020. PMID: 32712172 Review.
-
A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.Hum Mol Genet. 2016 Jun 1;25(11):2182-2193. doi: 10.1093/hmg/ddw085. Epub 2016 Apr 5. Hum Mol Genet. 2016. PMID: 27053713 Free PMC article.
-
Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).Mol Cell Proteomics. 2016 Apr;15(4):1435-52. doi: 10.1074/mcp.M115.054122. Epub 2016 Jan 19. Mol Cell Proteomics. 2016. PMID: 26785728 Free PMC article.
-
Unsuccessful intravenous D-mannose treatment in PMM2-CDG.Orphanet J Rare Dis. 2019 Oct 22;14(1):231. doi: 10.1186/s13023-019-1213-3. Orphanet J Rare Dis. 2019. PMID: 31640729 Free PMC article.
-
[Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].Duodecim. 2016;132(3):253-9. Duodecim. 2016. PMID: 26951030 Review. Finnish.
Cited by
-
Motor improvement in children with PMM2-CDG syndrome following a six-month rehabilitation treatment utilising whole-body vibration; a retrospective study.J Musculoskelet Neuronal Interact. 2024 Mar 1;24(1):12-21. J Musculoskelet Neuronal Interact. 2024. PMID: 38427364 Free PMC article.
-
Consequences of GMPPB deficiency for neuromuscular development and maintenance.Front Mol Neurosci. 2024 Feb 14;17:1356326. doi: 10.3389/fnmol.2024.1356326. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38419795 Free PMC article.
-
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P.Cell Res. 2023 Dec;33(12):904-922. doi: 10.1038/s41422-023-00848-6. Epub 2023 Jul 17. Cell Res. 2023. PMID: 37460805 Free PMC article.
-
Mitochondrial Control for Healthy and Autoimmune T Cells.Cells. 2023 Jul 7;12(13):1800. doi: 10.3390/cells12131800. Cells. 2023. PMID: 37443834 Free PMC article. Review.
-
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.Nat Commun. 2023 Apr 14;14(1):2132. doi: 10.1038/s41467-023-37652-0. Nat Commun. 2023. PMID: 37059720 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
